Related Experiment Video
Updated: May 5, 2026

Isolation of Brain-infiltrating Leukocytes
Published on: June 13, 2011
John Cunningham Virus and Progressive Multifocal Leukoencephalopathy: A Falsely Played Diagnosis
1Independent Researcher, 38500 Volos, Greece.
Abstract:
Progressive Multifocal Leukoencephalopathy (PML) is a possibly fatal demyelinating disease and John Cunningham Polyomavirus (JCPyV) is believed to cause this condition. The so-called JCPyV was initially reported in lymphoma and Human Immunodeficiency Virus (HIV) cases, whereas nowadays, its incidence is increasing in Multiple Sclerosis (MS) cases treated with natalizumab (Tysabri). However, there are conflicting literature data on its pathology and diagnosis, whereas some misdiagnosed reports exist, giving rise to further questions towards the topic. In reality, the so-called PML and the supposed JCPyV are not what they seem to be. In addition, novel and more frequent PML-like conditions may be reported, especially after the Coronavirus Disease 2019 (COVID-19) pandemic.
Insights
Progressive Multifocal Leukoencephalopathy (PML), a fatal demyelinating disease, is linked to John Cunningham Polyomavirus (JCPyV). However, emerging evidence suggests PML and JCPyV may not be what they seem, with new PML-like conditions appearing.
Area of Science:
- Neuroimmunology
- Viral Pathogenesis
- Demyelinating Diseases
Background:
- Progressive Multifocal Leukoencephalopathy (PML) is a severe demyelinating disease.
- John Cunningham Polyomavirus (JCPyV) is the suspected causative agent of PML.
- JCPyV is increasingly observed in Multiple Sclerosis (MS) patients treated with natalizumab.
Purpose of the Study:
- To investigate the complex etiology and diagnosis of PML.
- To address conflicting literature data regarding JCPyV and PML.
- To explore the emergence of novel PML-like conditions.
Main Methods:
- Literature review of JCPyV and PML cases.
- Analysis of diagnostic criteria and pathological findings.
- Epidemiological assessment of PML incidence post-COVID-19.
Main Results:
- Conflicting data exists on JCPyV's role in PML pathology and diagnosis.
- Misdiagnosis reports highlight diagnostic challenges.
- An increase in PML-like conditions is noted, particularly after COVID-19.
Conclusions:
- The understanding of PML and JCPyV requires re-evaluation.
- Diagnostic accuracy for PML and related conditions needs improvement.
- Emerging PML-like conditions warrant further investigation, especially in the context of recent pandemics.
Related Concept Videos
Viral Meningitis
Arboviral Encephalitis
Cytomegalovirus Disease
Bacterial Meningitis II: Pathophysiology
Encephalitis l: Introduction
Encephalitis ll: Pathophysiology

